JPH0788206B2 - Method for producing hydroxyapatite fine particle aggregate - Google Patents
Method for producing hydroxyapatite fine particle aggregateInfo
- Publication number
- JPH0788206B2 JPH0788206B2 JP63305636A JP30563688A JPH0788206B2 JP H0788206 B2 JPH0788206 B2 JP H0788206B2 JP 63305636 A JP63305636 A JP 63305636A JP 30563688 A JP30563688 A JP 30563688A JP H0788206 B2 JPH0788206 B2 JP H0788206B2
- Authority
- JP
- Japan
- Prior art keywords
- hap
- water
- fine particle
- particles
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000010419 fine particle Substances 0.000 title claims description 13
- 229910052588 hydroxylapatite Inorganic materials 0.000 title claims description 8
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 title claims description 8
- 238000004519 manufacturing process Methods 0.000 title claims description 7
- 239000002245 particle Substances 0.000 claims description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 150000001875 compounds Chemical class 0.000 claims description 12
- 239000002244 precipitate Substances 0.000 claims description 11
- 239000003960 organic solvent Substances 0.000 claims description 8
- 229910019142 PO4 Inorganic materials 0.000 claims description 6
- 229910052698 phosphorus Inorganic materials 0.000 claims description 6
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 5
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 5
- 239000010452 phosphate Substances 0.000 claims description 5
- 239000011574 phosphorus Substances 0.000 claims description 5
- 150000003839 salts Chemical class 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 4
- 229910052760 oxygen Inorganic materials 0.000 claims description 4
- 239000001301 oxygen Substances 0.000 claims description 4
- 230000015572 biosynthetic process Effects 0.000 claims description 3
- 238000002425 crystallisation Methods 0.000 claims 1
- 230000008025 crystallization Effects 0.000 claims 1
- 239000011575 calcium Substances 0.000 description 24
- 239000007788 liquid Substances 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- 239000000243 solution Substances 0.000 description 7
- -1 KH 2 PO 4 Chemical class 0.000 description 6
- 238000013375 chromatographic separation Methods 0.000 description 6
- 239000011259 mixed solution Substances 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- 235000021317 phosphate Nutrition 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 235000019441 ethanol Nutrition 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 230000036571 hydration Effects 0.000 description 3
- 238000006703 hydration reaction Methods 0.000 description 3
- 238000005342 ion exchange Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000012856 packing Methods 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000001308 synthesis method Methods 0.000 description 2
- WVLBCYQITXONBZ-UHFFFAOYSA-N trimethyl phosphate Chemical compound COP(=O)(OC)OC WVLBCYQITXONBZ-UHFFFAOYSA-N 0.000 description 2
- QQMXPYIHKPAZFM-UHFFFAOYSA-N CCO.CCO.CCO.OP(O)(O)=O Chemical compound CCO.CCO.CCO.OP(O)(O)=O QQMXPYIHKPAZFM-UHFFFAOYSA-N 0.000 description 1
- YIUHYXPIVIHBAM-UHFFFAOYSA-N CO.CO.CO.OP(O)(O)=O Chemical compound CO.CO.CO.OP(O)(O)=O YIUHYXPIVIHBAM-UHFFFAOYSA-N 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- OYCDTPQIKJZGBS-UHFFFAOYSA-N P(O)(O)(O)=O.[O] Chemical class P(O)(O)(O)=O.[O] OYCDTPQIKJZGBS-UHFFFAOYSA-N 0.000 description 1
- IDCBOTIENDVCBQ-UHFFFAOYSA-N TEPP Chemical compound CCOP(=O)(OCC)OP(=O)(OCC)OCC IDCBOTIENDVCBQ-UHFFFAOYSA-N 0.000 description 1
- 238000002441 X-ray diffraction Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000004703 alkoxides Chemical class 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 238000011074 autoclave method Methods 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- JHLCADGWXYCDQA-UHFFFAOYSA-N calcium;ethanolate Chemical compound [Ca+2].CC[O-].CC[O-] JHLCADGWXYCDQA-UHFFFAOYSA-N 0.000 description 1
- AMJQWGIYCROUQF-UHFFFAOYSA-N calcium;methanolate Chemical compound [Ca+2].[O-]C.[O-]C AMJQWGIYCROUQF-UHFFFAOYSA-N 0.000 description 1
- OEPJXTZQPRTGCX-UHFFFAOYSA-N calcium;propan-1-olate Chemical compound [Ca+2].CCC[O-].CCC[O-] OEPJXTZQPRTGCX-UHFFFAOYSA-N 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000011362 coarse particle Substances 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- UCQFCFPECQILOL-UHFFFAOYSA-N diethyl hydrogen phosphate Chemical compound CCOP(O)(=O)OCC UCQFCFPECQILOL-UHFFFAOYSA-N 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- ZJXZSIYSNXKHEA-UHFFFAOYSA-L ethyl phosphate(2-) Chemical compound CCOP([O-])([O-])=O ZJXZSIYSNXKHEA-UHFFFAOYSA-L 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000010304 firing Methods 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 230000006911 nucleation Effects 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 150000002927 oxygen compounds Chemical class 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 238000000634 powder X-ray diffraction Methods 0.000 description 1
- 239000011164 primary particle Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000012798 spherical particle Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- DQWPFSLDHJDLRL-UHFFFAOYSA-N triethyl phosphate Chemical compound CCOP(=O)(OCC)OCC DQWPFSLDHJDLRL-UHFFFAOYSA-N 0.000 description 1
- BDZBKCUKTQZUTL-UHFFFAOYSA-N triethyl phosphite Chemical compound CCOP(OCC)OCC BDZBKCUKTQZUTL-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Materials For Medical Uses (AREA)
Description
【発明の詳細な説明】 [産業上の利用分野] 本発明は、クロマトグラフィー分離用担体や成形体原料
として最適なヒドロキシアパタイト微粒子凝集体の製造
方法に関するものである。TECHNICAL FIELD The present invention relates to a method for producing an aggregate of hydroxyapatite fine particles, which is optimal as a carrier for chromatographic separation or a raw material for a molded body.
[従来の技術] CaO−P2O5系アパタトは主として生体材料として開発さ
れており、中でもヒドロキシアパタイト(以下HAPと記
すことがある)は人体の骨を形成する物質と同じ組成で
あり、生体内に挿入された場合、生体との親和性が良
く、自家骨との接合性も良いので、人工骨や人工歯など
の材料として用いられている。また蛋白質との親和性や
HAP自体の有するイオン交換能を利用してクロマトグラ
フィー用の充填材やイオン交換材などにも用いられてい
る。[Prior Art] CaO-P 2 O 5 system Apatato is mainly developed as biomaterials, among others (sometimes hereinafter referred to as HAP) Hydroxyapatite is the same composition as the material forming the body of the bone, raw When it is inserted into the body, it has a good affinity with living organisms and a good bondability with autologous bone, and is therefore used as a material for artificial bones and artificial teeth. Also the affinity with proteins
It is also used as a packing material for chromatography and as an ion exchange material by utilizing the ion exchange capacity of HAP itself.
蛋白質等の生体関連物質の分離・精製は医学・薬学分野
において益々強く要請されるようになり、例えば高速液
体クロマトグラフィーによる生体関連物質の分離・精製
技術が工業敵手段として注目されている。こうしたクロ
マトグラフィーの固定相に用いられる担体としては、上
記生体関連物質との親和性が良好であることが要求さ
れ、上記要求を満足するHAPがクロマトグラフィー分離
用担体として用いられる様になってきた。しかしながら
HAPの粒子径や形状を制御する技術が確立されていない
こと、およびHAPのCa/P比の再現性が悪いこと等によっ
て製造ロット毎に分離特性が変わってしまうという欠点
があり、その改善が望まれている。Separation / purification of bio-related substances such as proteins has been increasingly demanded in the medical and pharmaceutical fields, and for example, a technique for separating / purifying bio-related substances by high performance liquid chromatography has been attracting attention as an industrial enemy means. The carrier used for such a stationary phase of chromatography is required to have good affinity with the above-mentioned bio-related substance, and HAP satisfying the above requirements has come to be used as a carrier for chromatographic separation. . However
There is a drawback that the separation characteristics change for each production lot due to lack of established technology for controlling the particle size and shape of HAP, and poor reproducibility of HAP Ca / P ratio. Is desired.
高速液体クロマトグラフィーは、移動相を10〜30mm/sec
の高速で流して分離の高速化を図るものであるが、この
様な高速化に対処するには高圧力に耐え得るだけの強度
が担体に要求される。またクロマトグラフィーによる分
離能力を高く維持するには、担体の充填をクロマトグラ
フィーの近似的分布平衡状態にできるだけ維持すること
が必要である。特に担体の粒子径が100〜150μm程度の
大きさであると、移動相の高速状態下においては前記平
衡状態を維持することが困難である。従って前記平衡状
態を高速状態下で維持するには、担体の粒子径を充分細
かくすると共にその粒子径を揃えることが必要である。High performance liquid chromatography uses a mobile phase of 10 to 30 mm / sec.
In order to cope with such high speed, the carrier is required to have strength enough to withstand high pressure. Further, in order to maintain high chromatographic separation ability, it is necessary to keep the packing of the carrier in the approximate distribution equilibrium state of chromatography as much as possible. In particular, when the particle size of the carrier is about 100 to 150 μm, it is difficult to maintain the equilibrium state under the high-speed state of the mobile phase. Therefore, in order to maintain the equilibrium state at a high speed, it is necessary to make the particle diameter of the carrier sufficiently small and to make the particle diameter uniform.
クロマトグラフィー分離用担体として用いられるHAP
は、湿式法で合成されたものをそのまま或は造粒物とし
て使用するか、乾式合成法によって合成されたものを粉
砕分級して用いるのが一般的である。しかしながら粒径
10μm以下の微粒子とするにはいずれの方法によっても
歩留りが悪く、しかも形状や粒度分布等の面では前述し
た問題が未解決のまま残る。HAP used as a carrier for chromatographic separation
In general, the one synthesized by the wet method is used as it is or as a granulated product, or the one synthesized by the dry synthesis method is pulverized and classified and used. However particle size
The yield is poor by any method for making fine particles of 10 μm or less, and the above-mentioned problems remain unsolved in terms of shape and particle size distribution.
HAPの製造方法としては上述した方法以外にも種々の方
法が知られているが、例えばオートクレーブ法ではHAP
が杭状粒子となってしまい、CaHPO4を出発物質とする湿
式合成法では菱形となり、しかもいずれの方法によって
も10μm以下の微粒子形状として得ることは困難であ
る。これに対し燐酸の中和による方法では微粒子状HAP
が得られるが、コロイド状となり理想とする球状且つ一
粒子は得られない。尚スプレードライ法による造粒が行
なわれることもあるが、10μm以下の微粒子の歩留りが
悪いという難がある。Various methods other than the above-mentioned methods are known as a method for producing HAP. For example, in the autoclave method, HAP is used.
Become pile-shaped particles, and the wet synthesis method using CaHPO 4 as a starting material results in a rhombus shape, and it is difficult to obtain fine particles of 10 μm or less by any method. On the other hand, in the method of neutralizing phosphoric acid, fine particle HAP
However, the particles are colloidal, and ideal spherical particles cannot be obtained. Although granulation may be performed by a spray dry method, there is a problem that the yield of fine particles of 10 μm or less is poor.
一方HAP粉末を成形して焼成固化する場合において成形
体の密度をできるだけ高くするに当たっては、粉末の粒
子径ができるだけ小かく、しかも粒度分布の狭いことが
望まれている。しかしながら前記の方法で得られるHAP
粒子のサイズは数μmから10μm以上の粗粒のものであ
り、一次粒子のサイズがこのように大きいと充填率が低
くなり、密度を高めることが難しい。そこで粒子を細か
くしようとすれば結晶性が悪くなり、水分を多く含むた
め緻密成形体の焼成時における収縮率が大きくなり、か
つ不安定になるという問題を有していた。On the other hand, when the HAP powder is molded and fired and solidified, in order to increase the density of the molded body as much as possible, it is desired that the particle size of the powder be as small as possible and that the particle size distribution be narrow. However, HAP obtained by the above method
The particle size is a coarse particle size of several μm to 10 μm or more. When the size of the primary particle is such large, the packing rate becomes low and it is difficult to increase the density. Therefore, if the particles are made finer, the crystallinity is deteriorated, and since a large amount of water is contained, there is a problem that the shrinkage rate of the dense molded body during firing becomes large and becomes unstable.
[発明が解決しようとする課題] 本発明はこうした技術的課題を解決する為になされたも
のであって、その目的は、粒子形状を球状にすると共に
粒度を均一且つ微細にし、しかもCa/P比を再現性良く制
御でき、クロマトグラフィー分離用担体や成形体原料と
して最適なヒドロキシアパタイト微粒子凝集体の製造方
法を提供することにある。[Problems to be Solved by the Invention] The present invention has been made in order to solve these technical problems, and its object is to make the particle shape spherical and to make the particle size uniform and fine, and also to make Ca / P It is an object of the present invention to provide a method for producing a hydroxyapatite fine particle aggregate which is capable of controlling the ratio with good reproducibility and is optimal as a carrier for chromatographic separation or a raw material for a molded body.
[課題を解決する為の手段] 上記目的を達成し得た本発明とは、所定のCa/P比となる
ように非燐酸塩型の反応性Ca化合物および非Ca塩型の燐
の反応性酸素酸化合物を50℃以下の水および/または親
水性有機溶媒に溶解し、この溶液を水および/または親
水性有機溶媒に温度70℃以上、pH4以上に保ちつつ滴下
し、沈殿物の生成速度を制御することによって初期晶出
粒子を核とする凝集体を形成し、その沈殿物を回収する
点に要旨を有するヒドロキシアパタイト微粒子凝集体の
製造方法である。[Means for Solving the Problems] The present invention capable of achieving the above-mentioned object means that the reactivity of a non-phosphate type reactive Ca compound and a non-Ca salt type phosphorus is adjusted so that a predetermined Ca / P ratio is obtained. Oxygen acid compound is dissolved in water and / or hydrophilic organic solvent at 50 ° C or lower, and this solution is added dropwise to water and / or hydrophilic organic solvent while maintaining the temperature at 70 ° C or higher and pH 4 or higher to form precipitates. Is a method for producing a hydroxyapatite fine particle agglomerate, which is characterized in that an agglomerate having nucleation of the initial crystallized particles as a nucleus is formed by controlling the above, and the precipitate is collected.
[作用] 本発明者らは、CaとPの夫々の化合物を予め混合して一
液とした後、これを水和置換反応させればHAPのCa/P比
を再現性良く制御できることを見出し、その技術的意義
が認められたので先に特許出願した(特願昭62−326516
号)。そして本発明者らは上記技術を更に改良すべく、
その後も研究を重ねた。その結果水和置換反応における
HAP沈殿物の生成速度を適切に制御すれば、初期晶出粒
子を核としてHAP粒子が集合した凝集体ができることが
判明し、この凝集体の形状は球状且つ均一に生成するこ
とからクロマトグラフィー分離担体や成形体原料として
最適であることを見出し、本発明を完成した。尚沈殿物
の生成速度を制御する具体的手段としては、上記溶液の
水や親水性有機溶媒に対する過飽和度を少なくし且つ滴
下時に単独に新しい結晶核ができにくい程度に滴下速度
をコントロールすることが挙げられる。[Operation] The present inventors have found that the Ca / P ratio of HAP can be controlled with good reproducibility by previously mixing the respective compounds of Ca and P into a single liquid and then subjecting this to a hydration substitution reaction. Since its technical significance was recognized, a patent application was filed first (Japanese Patent Application No. 62-326516).
issue). And the present inventors, in order to further improve the above technology,
After that, research was repeated. As a result, in the hydration substitution reaction
By appropriately controlling the rate of HAP precipitate formation, it was revealed that aggregates of HAP particles with initial crystallized grains as nuclei were formed, and the shape of these aggregates was spherical and uniform. The present invention has been completed by finding that it is most suitable as a carrier or a raw material for a molded body. Incidentally, as a specific means for controlling the formation rate of the precipitate, it is possible to reduce the degree of supersaturation of the solution with respect to water or a hydrophilic organic solvent and control the dropping rate to such an extent that new crystal nuclei are not easily formed at the time of dropping. Can be mentioned.
本発明で用いる非燐酸塩型の反応性Ca化合物および非Ca
塩型の反応性酸素酸化合物は、水あるいは親水性有機溶
媒に可能なものであり、例えば非燐酸塩型の反応性Ca化
合物としてはCaCl2,Ca(No3)2,Ca(HCOO)2,Ca(CH3CO
O)2,Ca(OH)2,CaCO3等やカルシウムジメトキシド,カ
ルシウムジエトキシド,カルシウムジプロポキシド等の
Ca−アルコキシド類およびカルボン酸塩類等が非限定的
に例示される。The non-phosphate type reactive Ca compound and non-Ca used in the present invention
The salt type reactive oxygen acid compound can be used in water or a hydrophilic organic solvent. For example, as the non-phosphate type reactive Ca compound, CaCl 2 , Ca (No 3 ) 2 and Ca (HCOO) 2 , Ca (CH 3 CO
O) 2 , Ca (OH) 2 , CaCO 3, etc. and calcium dimethoxide, calcium diethoxide, calcium dipropoxide, etc.
Non-limiting examples include Ca-alkoxides and carboxylates.
また非Ca塩型の燐の反応性酸素化合物としては、H3PO4
あるいはKH2PO4,NH4H2PO4,(NH4)2HPO4,(NH4)3PO4等
の如き燐酸塩の他、燐酸トリメトキシド,燐酸トリエト
キシド,燐酸トリプロポキシド,亜燐酸トリメトキシ
ド,亜燐酸トリエトキシド,亜燐酸トリプロポキシド等
の各種燐の酸素酸のアルコキシド類や燐酸トリメチル,
メタ燐酸エチル,燐酸モノエチル,燐酸ジエチル,燐酸
トリエチル,ピロリン酸エチル等の各種燐の酸素酸のエ
ステル類が非限定的に例示される。As a reactive oxygen compound of non-Ca salt type phosphorus, H 3 PO 4
In addition to phosphates such as KH 2 PO 4 , NH 4 H 2 PO 4 , (NH 4 ) 2 HPO 4 and (NH 4 ) 3 PO 4, etc., phosphoric acid trimethoxide, phosphoric acid triethoxide, phosphoric acid tripropoxide, phosphorous acid trimethoxide. , Phosphite triethoxide, phosphite tripropoxide, and various phosphorus oxyacid alkoxides and trimethyl phosphate,
Non-limiting examples of various phosphoric acid oxygen esters such as ethyl metaphosphate, monoethyl phosphate, diethyl phosphate, triethyl phosphate, ethyl pyrophosphate, and the like.
前記非燐酸塩型の反応性Ca化合物および非Ca塩型の燐の
反応性酸素酸化合物を所定のCa/P比となるような配合で
50℃以下の水および/または親水性有機溶媒に溶解さ
せ、この溶解液を水および/または親水性溶媒に温度70
℃以上,pH4以上(好ましくは8〜11)に保ちつつ滴下
し、水和置換反応させてHAP微粒子凝集体の沈殿物を得
る。この際溶解液の温度を50℃以下とするのは溶解液中
での反応を制御するためである。The non-phosphate type reactive Ca compound and the non-Ca salt type phosphorus reactive oxygen acid compound are blended so as to have a predetermined Ca / P ratio.
Dissolve in water and / or hydrophilic organic solvent at 50 ° C or below, and dissolve this solution in water and / or hydrophilic solvent at temperature 70
While being kept at a temperature of not less than 0 ° C and a pH of not less than 4 (preferably 8 to 11), the mixture is allowed to undergo a hydration substitution reaction to obtain a precipitate of HAP fine particle aggregates. At this time, the temperature of the solution is set to 50 ° C. or lower in order to control the reaction in the solution.
また被滴下液の温度を70℃以上に保つとともにKOH,NaO
H,NH4OH等のアルカリを滴下してpHを4以上(好ましく
は8〜11)に保つのは、被滴下液の温度が70℃未満では
生成HAPが非晶質相との混合晶となってしまい、また結
晶性も悪くなってしまうからであり、被滴下液の温度は
70℃以上とする。被滴下液がpH4未満では沈殿物が生成
せず、仮に生成したとしてもHAP微粒子が再溶解し、生
成物の粒子形状や化学組成が不安定になるのでpH4以上
(好ましくは8〜11)に保つことが必要である。尚pHを
制御することによって、粒度の調整も可能である(後記
実施例1参照)。In addition, keep the temperature of the liquid to be dropped above 70 ℃ and
The reason for maintaining the pH at 4 or higher (preferably 8 to 11) by dropping an alkali such as H, NH 4 OH is that when the temperature of the liquid to be dripped is less than 70 ° C., HAP produced is a mixed crystal with an amorphous phase. And the crystallinity also deteriorates, and the temperature of the liquid to be dropped is
70 ℃ or more. If the liquid to be dripped is less than pH 4, no precipitate will be generated, and even if it is generated, HAP fine particles will be redissolved and the particle shape and chemical composition of the product will be unstable, so the pH should be 4 or higher (preferably 8 to 11). It is necessary to keep. The particle size can be adjusted by controlling the pH (see Example 1 below).
前記Ca化合物および前記P化合物を溶解する液あるいは
溶解液を滴下する被滴下液の水以外の親水性有機溶媒と
しては、メタノール,エタノール,アセトン,エーテル
等が例示され、水和反応置換に際しては溶解液および被
滴下液として同じものあるいは異なるものを使用しても
良い。Examples of the hydrophilic organic solvent other than water in the liquid in which the Ca compound and the P compound are dissolved or the liquid to be dropped in which the dissolution liquid is dropped include methanol, ethanol, acetone, ether, etc. The same liquid or different liquid may be used as the liquid and the liquid to be dropped.
以下本発明を実施例によって更に詳細に説明するが、下
記実施例は本発明方法の一具体例を示しただけであっ
て、前・後記の趣旨に徴して設計変更することはいずれ
も本発明の技術的範囲に含まれるものである。Hereinafter, the present invention will be described in more detail with reference to Examples. However, the following Examples merely show one specific example of the method of the present invention, and any modification of the design can be made without departing from the spirit of the preceding and the following. Are included in the technical scope of.
[実施例] 実施例1 CaCl2とH3PO4(85%濃度)を所定のCa/Pモル比となる様
に25℃のイオン交換水1に溶解し、混合溶液とした。Example 1 Example 1 CaCl 2 and H 3 PO 4 (85% concentration) were dissolved in ion-exchanged water 1 at 25 ° C. so as to have a predetermined Ca / P molar ratio, to prepare a mixed solution.
続いて70℃のイオン交換水1にこの温度を保ちつつ、
pHコントローラに接続したマイクロチューブポンプでKO
H水溶液を加えてpHを制御するとともに前記混合液を滴
下したところ、乳白色の懸濁液を得た。この懸濁液を2
時間保持した後、メンブランフィルターにて濾過し、Ag
NO3水溶液による瀘液の白濁化が認められなくなるまで
純水で洗浄した。得られた沈殿物を100℃にて乾燥後粉
末X線回折に付した結果によると、すべてHAPの単相で
あった。また透過電子顕微鏡による粒子形状の観察で
は、針状粒子が集合した均一な球状凝集体であった。ま
た得られたHAPのCa/P比は原料の配合比とほぼ符合する
ものであった。このときのpHと粒子径との関係を第1表
に示す。Next, while maintaining this temperature in ion-exchanged water 1 at 70 ° C,
KO with micro tube pump connected to pH controller
When the H solution was added to control the pH and the mixed solution was added dropwise, a milky white suspension was obtained. 2 this suspension
After holding for a while, filter with a membrane filter to remove Ag.
It was washed with pure water until no white turbidity of the filtrate due to the NO 3 aqueous solution was observed. The obtained precipitate was dried at 100 ° C. and then subjected to powder X-ray diffraction. According to the result, all were HAP single phase. Observation of the particle shape by a transmission electron microscope revealed that the particles were uniform spherical aggregates of acicular particles. The Ca / P ratio of the obtained HAP was almost in agreement with the blending ratio of the raw materials. Table 1 shows the relationship between pH and particle size at this time.
実施例2 Caジエトキシド13gをエチレングリコール72.6gに溶解
し、これを亜燐酸トリエチル10gを溶解したエチルアル
コール100ccに混合して混合溶液とした。無水酢酸32gを
エチルアルコール100ccに溶解した溶液に上記混合溶液
を滴下したところ、乳白色の懸濁液を得た。該懸濁液を
実施例と同様に濾過・乾燥した後、得られた沈殿物をX
線回折したところ、球状且つ均一なHAP微粒子凝集体で
あることが分かった。 Example 2 13 g of Ca diethoxide was dissolved in 72.6 g of ethylene glycol, and this was mixed with 100 cc of ethyl alcohol in which 10 g of triethyl phosphite was dissolved to prepare a mixed solution. When the above mixed solution was added dropwise to a solution of 32 g of acetic anhydride dissolved in 100 cc of ethyl alcohol, a milky white suspension was obtained. The suspension thus obtained was filtered and dried in the same manner as in the Example, and the obtained precipitate was separated by X.
Line diffraction revealed that the particles were spherical and uniform HAP fine particle aggregates.
またこの凝集体のCa/P比は1.67であった。The Ca / P ratio of this aggregate was 1.67.
実施例3 Ca/P比が所定の値となる様に、Caジエトキシドと燐酸ト
リメチルを25℃のエチルアルコールに溶解して混合溶液
を得た。続いて70℃のイオン交換水中に、pHコントロー
ラに接続したマイクロチューブでKOH水溶液を加えてpH
を7以上に制御しながら前記混合溶液を滴下したとこ
ろ、乳白色の懸濁液を得た。該懸濁液を実施例1と同様
に濾過・乾燥した後、得られた沈殿物をX線回折したと
ころ、ヒドロキシアパタイト単相であることが確認され
た。また得られたHAPは、実施例1のときと同様の形状
であった。Example 3 Ca diethoxide and trimethyl phosphate were dissolved in ethyl alcohol at 25 ° C. to obtain a mixed solution so that the Ca / P ratio was a predetermined value. Next, add KOH aqueous solution to the pH in ion exchange water at 70 ° C with a microtube connected to a pH controller.
When the mixed solution was added dropwise while controlling the ratio to 7 or more, a milky white suspension was obtained. After the suspension was filtered and dried in the same manner as in Example 1, the precipitate obtained was subjected to X-ray diffraction, and it was confirmed to be a hydroxyapatite single phase. The obtained HAP had the same shape as in Example 1.
[発明の効果] 以上述べた如く本発明によれば、クロマトグラフィー分
離用担体や成形体原料として最適なヒドロキシアパタイ
ト微粒子凝集体が得られた。[Effects of the Invention] As described above, according to the present invention, an optimum hydroxyapatite fine particle aggregate as a carrier for chromatographic separation or a raw material for a molded body was obtained.
Claims (1)
応性Ca化合物および非Ca塩型の燐の反応性酸素酸化合物
を50℃以下の水および/または親水性有機溶媒に溶解
し、この溶液を水および/または親水性有機溶媒に温度
70℃以上、pH4以上に保ちつつ滴下し、沈殿物の生成速
度を制御することによって初期晶出粒子を核とする凝集
体を形成し、その沈殿物を回収することを特徴とするヒ
ドロキシアパタイト微粒子凝集体の製造方法。1. A non-phosphate type reactive Ca compound and a non-Ca salt type reactive oxygen acid compound of phosphorus so that a predetermined Ca / P ratio is obtained, water and / or a hydrophilic organic solvent at 50 ° C. or lower. And dissolve the solution in water and / or a hydrophilic organic solvent at a temperature
Hydroxyapatite fine particles characterized by being formed by dropping while maintaining at 70 ° C or higher and pH 4 or higher to control the rate of formation of precipitates and forming aggregates with the initial crystallization particles as nuclei and recovering the precipitates. A method for producing an aggregate.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP63305636A JPH0788206B2 (en) | 1988-12-01 | 1988-12-01 | Method for producing hydroxyapatite fine particle aggregate |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP63305636A JPH0788206B2 (en) | 1988-12-01 | 1988-12-01 | Method for producing hydroxyapatite fine particle aggregate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH02149408A JPH02149408A (en) | 1990-06-08 |
| JPH0788206B2 true JPH0788206B2 (en) | 1995-09-27 |
Family
ID=17947517
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP63305636A Expired - Lifetime JPH0788206B2 (en) | 1988-12-01 | 1988-12-01 | Method for producing hydroxyapatite fine particle aggregate |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0788206B2 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH09301708A (en) * | 1996-05-08 | 1997-11-25 | Nippon Chem Ind Co Ltd | Apatite slurry and method for producing the same |
| US5939039A (en) * | 1997-01-16 | 1999-08-17 | Orthovita, Inc. | Methods for production of calcium phosphate |
| DE69723866T2 (en) * | 1997-10-08 | 2004-07-15 | Nippon Chemical Industrial Co., Ltd. | APATITE SLURGE AND METHOD FOR PRODUCING THE SAME |
| JP4642180B2 (en) * | 2000-04-05 | 2011-03-02 | 旭化成ケミカルズ株式会社 | Method for producing acicular apatite particles |
| US9220595B2 (en) | 2004-06-23 | 2015-12-29 | Orthovita, Inc. | Shapeable bone graft substitute and instruments for delivery thereof |
-
1988
- 1988-12-01 JP JP63305636A patent/JPH0788206B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JPH02149408A (en) | 1990-06-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5427754A (en) | Method for production of platelike hydroxyapatite | |
| Cheng et al. | Silk fibroin‐regulated crystallization of calcium carbonate | |
| JP2543685B2 (en) | Method for producing calcium phosphate | |
| US20050226939A1 (en) | Production of nano-sized hydroxyapatite particles | |
| CN103071447B (en) | Method for preparing strontium-doped hydroxyapatite through supersound | |
| JP3028375B2 (en) | Apatite whisker and method for producing the same | |
| JPS6287406A (en) | Production of beta-tricalcium phosphate | |
| CN102897734A (en) | Calcium phosphate nano-structures and preparation method thereof | |
| KR101017815B1 (en) | Method for producing calcium phosphate particles by solution growth method | |
| JPH0788206B2 (en) | Method for producing hydroxyapatite fine particle aggregate | |
| WO2003042098A1 (en) | Granular zirconium phosphate and methods for synthesis of same | |
| RU2402483C2 (en) | Method of preparing nanodispersed hydroxyapatite for medicine | |
| CN107572493B (en) | A kind of preparation method of dandelion-shaped hollow hydroxyapatite containing rosin functional group | |
| JP2756703B2 (en) | Spherical apatite, method for producing the same, and molded article with porous structure | |
| JPH0444606B2 (en) | ||
| JP5544813B2 (en) | Method for producing spherical hydroxyapatite | |
| JP2572793B2 (en) | Method for producing hydroxyapatite fine particles | |
| CN101205058B (en) | A kind of preparation method of micron spherical hydroxyapatite | |
| CN114890398A (en) | Hydroxyapatite microspheres and preparation method thereof | |
| JPH0832552B2 (en) | Hydroxyapatite fine single crystal and method for producing the same | |
| JP2006273710A (en) | Method for synthesizing aluminophosphates | |
| RU2657817C1 (en) | Method for producing ceramic powder based on hydroxyapatite and wollastonite | |
| CN110615417B (en) | Porous structure calcium phosphate organic-inorganic composite material and preparation method thereof | |
| CN110510592A (en) | The method that regulation preparation has the hydroxyapatite of superior cell compatibility | |
| RU2165389C1 (en) | Method of preparing finely dispersed single-phase hydroxyl apatite |